Liver Symposium

2027 LIVER SYMPOSIUM

SAVE THE DATE

Saturday,

January 30, 2027

InterContinental San Francisco

San Francisco, CA

8:00 AM–5:00 PM

FACULTY

VENUE

Earn AMA PRA Category 1 Credits™ or MOC points!

The Northern California Society for Clinical Gastroenterology (NCSCG) Board and Meeting Planning Committee are pleased to announce that the 2027 Liver Symposium will be held in person at the InterContinental Hotel in San Francisco, California, on January 30, 2027.

This year’s symposium will offer a comprehensive and authoritative update on liver diseases, presented by nationally recognized experts in the field. Attendees will have valuable opportunities to engage with colleagues, interact with distinguished faculty, meet with industry representatives, and participate in discussions that advance clinical knowledge and practice. The program is designed to support meaningful professional exchange while allowing time to experience the exceptional setting of San Francisco.

Registration will open in late summer! Please feel free to contact the NCSCG with any questions or comments by sending an email to ncscg@pacemedcomm.com.

Sincerely,

2026 NCSCG LIVER PLANNING COMMITTEE

Course Directors

COURSE DIRECTORS

MIKHAIL ALPER, PA-C

California Gastroenterology Associates

Madera, CA

BILAL HAMEED, MD

University of California, San Francisco

San Francisco, CA

MARINA ROYTMAN, MD

University of California, San Francisco Fresno

Fresno, CA

ROSA VALADAO, MD

Kaiser Permanente

Oakland, CA

KIDIST YIMAM, MD

CPMC

San Francisco, CA

TARGET AUDIENCE

This activity has been designed to meet the educational needs of physicians, physician assistants and nurse practitioners involved in the care of patients with chronic liver disease (CLD).

STATEMENT OF NEED

The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease (CLD).

EDUCATIONAL OBJECTIVES

Upon completion of this symposium, participants should be better able to:

Describe current guidelines for the treatment and management of patients with chronic liver disease (CLD)
Employ an evidence-based approach to the management of CLD
Optimize treatment results for patients with CLD utilizing new therapies

Jointly provided by the Medical Education Resources and the Northern California Society for Clinical Gastroenterology (NCSCG).

Fees